YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Merck & Co. has agreed to acquire Cidara Therapeutics Inc. in a deal valued at $9.2 billion.
Bloomberg reports the deal is part of Merck & Co.'s ongoing efforts to make up for an upcoming patent loss of cancer drug Keytruda.
Cidara is a biotech company developing a flu treatment.
Read more from Bloomberg.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach